Both additives address common patient experiences during GLP-1 therapy: reduced energy from caloric deficit, and the desire to support active fat metabolism
In the NEJM Phase 2 trial, participants assigned to an initial dose of 4 mg experienced significantly more adverse events than those who started at 2 mg, even when both groups ultimately reached the same target dose
In a conversation with Forbes India late last year before the March correctionWinselow Tucker, president and general manager of Eli Lilly India, had already flagged the generic question, even as he downplayed it as a direct threat
Lip, Jeffrey V
FDA has also warned that poor compounding practices can create contamination or potency problems, although that concern applies to compounded drugs generally rather than proving that every compounded GLP-1 product is contaminated
His method and focus was on the food he ate and changing what he ate with the help of his chef and nutritionist, Ian Larios